Melanotan II

Melanotan II is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone developed for laboratory investigation of melanocortin systems. It functions as a non-selective agonist across multiple melanocortin receptors, offering broader activity than the more selective Melanotan I. Researchers employ this compound to probe both peripheral pigmentation pathways and central signaling networks in controlled experimental settings. Its cyclic structure supports stability during in-vitro handling and assay work.

Melanotan II binds and activates several melanocortin receptor subtypes, including MC1R and MC4R, with comparatively lower selectivity than related analogs. MC1R engagement is examined for its influence on melanogenic enzyme cascades within melanocyte culture systems. Concurrent MC4R interaction permits study of central melanocortin circuits that regulate energy homeostasis and related behavioral outputs in laboratory models. This multi-receptor profile enables side-by-side comparison of pathway contributions.

Research with Melanotan II concentrates on non-selective melanocortin signaling and its dual impact on melanogenesis plus central regulatory routes. Cellular and tissue models are used to quantify effects on pigment production pathways. Parallel investigations explore MC4R-mediated influences on appetite-related and sexual-behavior circuits within experimental laboratory systems. The compound thereby serves as a comparative tool against MC1R-selective agents such as Melanotan I.

Laboratory work has shown that Melanotan II elevates melanin-related markers through MC1R activation in melanocyte-based assays. Separate studies of its MC4R activity have mapped changes in feeding patterns and associated behavioral readouts inside controlled model systems. These observations illustrate the peptide’s utility for dissecting overlapping melanocortin functions. Comparative data further highlight differences in receptor breadth relative to linear or more selective analogs.

Melanotan II is supplied exclusively for in-vitro and laboratory research use and must never be directed toward human or animal consumption. The lyophilized material is typically reconstituted in sterile research-grade diluents under aseptic conditions. Storage at refrigerated or frozen temperatures helps preserve peptide integrity for experimental timelines. Standard laboratory peptide-handling protocols and institutional safety guidelines apply throughout all procedures.